These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2560690)

  • 21. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.
    De Cosmo S; Miscio G; Zucaro L; Margaglione M; Argiolas A; Thomas S; Piras G; Trevisan R; Perin PC; Bacci S; Frittitta L; Pizzuti A; Tassi V; Di Minno G; Viberti G; Trischitta V
    Nephrol Dial Transplant; 2002 Aug; 17(8):1402-7. PubMed ID: 12147786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nikzamir A; Nakhjavani M; Esteghamati A; Rashidi A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y; Yoshizumi H; Yoshinari M; Iino K; Yamamoto M; Ichikawa K; Iwase M; Fujishima M
    Diabetologia; 1996 Jan; 39(1):97-102. PubMed ID: 8720609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes.
    Solini A; Dalla Vestra M; Saller A; Nosadini R; Crepaldi G; Fioretto P
    Diabetes; 2002 Jan; 51(1):251-5. PubMed ID: 11756350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
    Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
    Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
    Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [I/D relationship between polymorphism of ACE gene and progression of chronic glomerulonephritis].
    Kaliev RR; Budaĭchiev AB; Aldashev AA; Mirrakhimov MM
    Ter Arkh; 2005; 77(6):12-5. PubMed ID: 16078593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum angiotensin converting enzyme activity in diabetes mellitus is not a uniform finding.
    Bor MV
    Cell Biochem Funct; 2001 Mar; 19(1):69-71, 73-4. PubMed ID: 11223874
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
    Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
    Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease.
    Fava S; Azzopardi J; Ellard S; Hattersley AT
    Diabetes Care; 2001 Dec; 24(12):2115-20. PubMed ID: 11723093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
    Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Parving HH
    Diabetes; 1995 May; 44(5):489-94. PubMed ID: 7729604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum angiotensin-converting enzyme: elevations in diabetes mellitus.
    Lieberman J; Sastre A
    Ann Intern Med; 1980 Dec; 93(6):825-6. PubMed ID: 6255846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective effect of the addition of losartan to ongoing treatment with an angiotensin converting enzyme inhibitor in type-2 diabetic patients with nephropathy.
    Abe H; Minatoguchi S; Ohashi H; Murata I; Minagawa T; Okuma T; Yokoyama H; Takatsu H; Takaya T; Nagano T; Osumi Y; Kakami M; Tsukamoto T; Tanaka T; Hiei K; Fujiwara H
    Hypertens Res; 2007 Oct; 30(10):929-35. PubMed ID: 18049024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy.
    Wang G; Lai FM; Lai KB; Chow KM; Kwan CH; Li KT; Szeto CC
    Diabetologia; 2008 Jun; 51(6):1062-7. PubMed ID: 18389211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients.
    Araz M; Yilmaz N; Güngör K; Okan V; Kepekci Y; Sükrü Aynacioglu A
    Diabetes Res Clin Pract; 2001 Nov; 54(2):95-104. PubMed ID: 11640993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.
    Huang W; Gallois Y; Bouby N; Bruneval P; Heudes D; Belair MF; Krege JH; Meneton P; Marre M; Smithies O; Alhenc-Gelas F
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13330-4. PubMed ID: 11687636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease.
    Schernthaner G; Schwarzer C; Kuzmits R; Müller MM; Klemen U; Freyler H
    J Clin Pathol; 1984 Mar; 37(3):307-12. PubMed ID: 6321559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
    Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
    Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.
    Marre M; Bernadet P; Gallois Y; Savagner F; Guyene TT; Hallab M; Cambien F; Passa P; Alhenc-Gelas F
    Diabetes; 1994 Mar; 43(3):384-8. PubMed ID: 8314010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.